Pre‑tax operating cash flow increased significantly year‑on‑year, though the company attributed part of the movement to planned working‑capital investment needed to ramp production.
Despite market volatility, CSG reaffirmed its full‑year 2026 revenue guidance of €7.4 billion to €7.6 billion.
The guidance suggests continued expansion after a breakout 2025, when the company reported €6.7 billion in revenue, up 71.7% year‑on‑year. That surge was driven by strong defence demand and the integration of acquired businesses such as The Kinetic Group.
Management has indicated that operating profitability should remain broadly stable, with margins expected to stay within the company’s mid‑20% target range.
CSG listed on Euronext Amsterdam in early 2026, raising roughly €3.8 billion in one of the largest defence‑sector IPOs in Europe.
However, the stock quickly came under pressure. Reports indicate that the shares:
The decline has been linked to investor concerns including:
Public reporting references the allegations but does not include the original short‑seller analysis, so the underlying claims cannot be independently assessed from the available evidence.
Operationally, the company continues to benefit from a strong demand cycle for defence equipment.
Key growth drivers include:
1. Rising European defence spending
European governments are increasing military budgets, boosting demand for artillery, ammunition, air‑defence systems, and defence electronics—core markets for CSG.
2. Large confirmed backlog
The company reported a €15 billion order backlog and a €27 billion opportunity pipeline, providing multi‑year revenue visibility.
3. Major new contracts
CSG has highlighted large contract opportunities, including reported $2.5 billion air‑defence system deals, that could support future growth.
4. Production expansion
To meet demand, the company has said it plans to increase in‑house ammunition output by about 20% in 2026.
The company’s financial performance paints a positive operational picture: rising revenue, strong margins, and a sizable order pipeline.
Yet the investment case remains contested. While analysts highlight the long‑term defence spending cycle as a major tailwind, market skepticism has emerged because of the share‑price collapse following the IPO and scrutiny of certain contracts and acquisitions.
In practical terms, CSG’s story now splits into two narratives:
How those two forces resolve—continued earnings growth versus investor confidence—will likely determine the trajectory of the company’s stock over the next several quarters.
Comments
0 comments